Cargando…
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
Although antibiotic treatment for Lyme disease is effective in the majority of cases, especially during the early phase of the disease, a minority of patients suffer from post-treatment Lyme disease syndrome (PTLDS). It is unclear what mechanisms drive this problem, and although slow or ineffective...
Autores principales: | Feng, Jie, Wang, Ting, Shi, Wanliang, Zhang, Shuo, Sullivan, David, Auwaerter, Paul G, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126181/ https://www.ncbi.nlm.nih.gov/pubmed/26038747 http://dx.doi.org/10.1038/emi.2014.53 |
Ejemplares similares
-
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
por: Feng, Jie, et al.
Publicado: (2015) -
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
por: Feng, Jie, et al.
Publicado: (2016) -
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
por: Feng, Jie, et al.
Publicado: (2015) -
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
por: Feng, Jie, et al.
Publicado: (2015) -
Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
por: Feng, Jie, et al.
Publicado: (2015)